Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon
  • GE CCTA

    New scanners and strategies for the ‘golden age of CCTA’

    As coronary CT angiography (CCTA) continues its rapid expansion, scanner vendors are now offering more economical solutions to ensure access to imaging technology beyond premium systems most often only found at flagship hospitals and academic centers. To conquer CCTA’s technical challenges, new technologies and AI are being incorporated into a new scanner to simplify acquisition and consistently improve image quality. 

  • Using a left radial artery (LRA) vs. hyper-adducted right radial artery (HARRA) approach in the cath lab

    Choosing left radial access in the cath lab helps cardiologists limit radiation exposure

    Using a left radial artery approach in the cath lab exposes interventional cardiologists to significantly less radiation than a hyper-adducted right radial artery approach. The difference is substantial enough for researchers to declare LRA "the primary access site for cardiac catheterization."

  • doctor examines patient data on their tablet

    Enabling X-ray-free ablation procedures in the EP lab

    Exposure to scatter radiation and orthopedic issues related to years of wearing lead aprons during long EP procedures has led electrophysiologists to seek out new ways to reduce the need for angiographic X-ray.

  • Cardiologist Heart Doctor Tablet Technology

    The evolution of RF technology to reduce complications and improve outcomes

    Advancements in radiofrequency (RF) catheter ablation technology have been incremental over the past 30 years in efforts to improve safety, procedural efficiency and patient outcomes. While some newer technologies have gained a lot of attention in electrophysiology (EP) over the past several years, RF remains the solid frontline treatment.

  • Eric Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM, director of vascular intervention, Beth Israel Deaconess, section head, interventional cardiology and vascular research, Susan F. Smith Center for Outcomes Research, and associate professor of medicine, Harvard Medical School, explained some of the new bioresorbable stent scaffold technology that is being developed for use in PAD below the knee at CRT 2025.

    Advances in bioresorbable stents show promise for treating PAD

    Bioresorbable stents are back in the spotlight thanks to some significant progress from multiple medtech companies. Eric Secemsky, MD, discussed some of the biggest breakthroughs in this space at CRT 2025.

George Dangas, MD, 2023-24 president of SCAI, director of cardiovascular innovation at Mount Sinai Hospital, and director of the TCT meeting, explains key trends he sees in interventional cardiology.

New directions and trends in interventional cardiology

Interventional cardiology continues to evolve, driven by rapid advancements in technology. George Dangas, MD, discussed some of the specialty's biggest ongoing trends with Cardiovascular Business. 

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Valve durability after TAVR: Cardiologists track how deterioration influences outcomes

Researchers have made it a priority to learn as much about the durability of TAVR valves as possible. A new study in JACC: Cardiovascular Interventions used updated VARC-3 definitions to identify signs of hemodynamic valve deterioration in nearly 2,500 patients.

AI-powered heart assessments of NFL veterans could help cardiologists tackle CVD

Retired NFL players Joel Dreessen and Le-Lo Lang are among the first athletes participating in a new registry launched by HeartFlow and the Boone Heart Institute.

Rakesh Gopinathannair, MD, FAHA, FACC, FHRS, director of cardiac electrophysiology laboratories at the Kansas City Heart Rhythm Institute, explains lessons from the AHA statement on COVID caused arrhythmias.

Key details associated with the treatment of COVID-induced arrhythmias

Rakesh Gopinathannair, MD, lead author of a recent American Heart Association scientific statement on cardiac arrhythmias associated with COVID-19, reviewed the latest science associated with this important topic.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Experts in interventional cardiology, medical billing unite to discuss Shockwave Medical’s IVL technology

Intravascular lithotripsy has quickly emerged as one of healthcare’s most in-demand technologies. Now Shockwave Medical, part of Johnson & Johnson MedTech, is co-hosting a webinar designed to teach coding and billing specialists how to code appropriately for peripheral and coronary IVL procedures. 

cardiologist viewing heart data

Aortic valve calcium scores help predict need for a permanent pacemaker after TAVR

RBBB remains the single strongest predictor for PPMI after TAVR, but high AV calcium scores still provide care teams with considerable value.

Medtronic's PulseSelect Pulse Field Ablation (PFA) System

Medtronic heart rhythm technologies on full display at AF Symposium 2025

Cardiologists shared updated data on Medtronic's ICM and PFA offerings during AF Symposium 2025 in Boston. 

The Medtronic SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing, providing users with another option when treating patients for bradycardia. According to Medtronic, this marks the first time the FDA has approved a device for this indication.

New research highlights rising interest in LBBAP

The first patient has been enrolled in a new study of an optimized lead for LBBAP, an area with an explosion of interest in EP as a way to improve patient outcomes.

Displaying 49 - 56 of 2717

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.